VRS
KNSA icon

Virginia Retirement Systems’s Kiniksa Pharmaceuticals KNSA Stock Holding History

Virginia Retirement Systems’s Portfolio KNSA Stock Details KNSA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$256K Buy
+4,000
New +$207K ﹤0.01% 1182
2023
Q3 		$438K Sell
25,200
-7,100
-22% -$120K ﹤0.01% 736
2023
Q2 		$455K Buy
32,300
+16,400
+103% +$220K ﹤0.01% 742
2023
Q1 		$171K Buy
+15,900
New +$209K ﹤0.01% 970

Other funds holding KNSA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
SSC
Spruce Street Capital New York $510M AUM

Virginia Retirement Systems's KNSA Position: Q2 2026 in Review

Virginia Retirement Systems opened a new position in Kiniksa Pharmaceuticals (KNSA) in Q2 2026: 4,000 shares worth $256K. The stake represents ﹤0.01% of the portfolio and ranks #1182 among its holdings. This is a return to the name: Virginia Retirement Systems previously reported a position in KNSA as recently as Q3 2023.

Virginia Retirement Systems first reported a position in KNSA in Q1 2023 and has held it in 4 quarters since. The position peaked at $455K in Q2 2023. 266 funds tracked by Wall St. Rank hold KNSA as of Q2 2026.

  • Virginia Retirement Systems held 4,000 shares of Kiniksa Pharmaceuticals worth $256K as of Q2 2026.
  • Kiniksa Pharmaceuticals was a new Virginia Retirement Systems position in Q2 2026.
  • Kiniksa Pharmaceuticals made up ﹤0.01% of Virginia Retirement Systems's portfolio in Q2 2026, its #1182 holding.
  • Virginia Retirement Systems first reported a position in Kiniksa Pharmaceuticals in Q1 2023 and has held it in 4 quarters since.
  • Virginia Retirement Systems's Kiniksa Pharmaceuticals position peaked at $455K in Q2 2023.
  • 266 funds tracked by Wall St. Rank held Kiniksa Pharmaceuticals as of Q2 2026.

Based on Virginia Retirement Systems's 13F filing for Q2 2026, filed 25 Aug 2026.